Valneva’s global manufacturing network includes three in-house operations to cover the internal and external production of clinical and commercial products.

Valneva provides state-of-the-art manufacturing according to Good Manufacturing Practice (GMP) guidelines, including quality assurance and control capabilities for the production and release of commercial and clinical trial products. The Company extends its manufacturing network through partnerships with various contract manufacturing organizations (CMOs). Valneva also leverages its capabilities in product development and clinical trial materials manufacturing with third parties by providing the following services:

  • Technical development (process and assay development for viral and bacterial vaccines)
  • Clinical immunology assay development and sample testing services
  • Clinical manufacturing
  • In vivo testing for preclinical proof of concept (PoC), immunogenicity and safety assessments
  • General facility services
  • Clinical strategy and operations for clinical-stage vaccine programs

Manufacturing and Services Sites

Livingston, Scotland – Manufacturing site

Valneva’s FDA approved manufacturing site in Livingston located just outside Edinburgh and is currently dedicated to drug substance production for our viral vaccines.

Solna, Sweden – Manufacturing site

Just outside Stockholm is Valneva’s manufacturing site in Solna. The site has a long tradition of vaccine manufacturing connected to Sweden’s state- owned vaccine institute.

Vienna, Austria – Dedicated GMP facilities

Co-located with Valneva’s development center in Vienna (Austria), the Company operates GMP laboratories and facilities for the testing and quality control of Valneva’s commercial and clinical stage vaccines.